Resonance Health (ASX:RHT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Resonance Health (ASX:RHT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Liver Fibrosis Device Progress & FY26 Portfolio Webinar
Resonance Health advances MRI Liver Fibrosis Device with FY26 portfolio update and webinar
Change of Director's Interest Notice - Dr David Fuller
Profit Guidance Upgrade
Resonance Health upgrades FY26 EBITDA guidance by 30% amid margin expansion and operational growth
Quarterly Activities/Appendix 4C Cash Flow Report
Resonance Health reports strong cash flow, near completion of $13.8M clinical trial, and record $10M+ SaMD order pipeline
Initial Director's Interest Notice - Michael Sistenich
Initial Director's Interest Notice - Dr David Fuller
Director Appointments